Delivery Order SPE2DB22D9112-SPE2DB24FTKGC

Award Date 9/27/24
Potential Completion Date 10/21/24
Potential Value $35K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,751.19 firm fixed-price delivery order is for the supply of Ocaliva 10 mg tablets. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $89,755.68 firm fixed-price delivery order is for the supply of Ocaliva 5mg tablets to support the recurring medical needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) under its Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,748.97 firm fixed-price delivery order is for the supply of 4564539373 (Ocaliva 5 mg Tablet 30s), a pharmaceutical product, with a period of performance through May 28, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,497.94 firm fixed-price delivery order is for the supply of the drug Ocaliva 5 mg Tablet 30s, with a period of performance through September 18, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DLA under the SPE2DB program, which allows for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,689.52, is for the supply of Ocaliva 5 mg tablets. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the DLA to issue delivery orders for a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,748.97 firm fixed-price delivery order is for the supply of 4565693343 ! OCALIVA 5 MG TABLET 30S. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a delivery order under the DLA's SPE2DB Indefinite Delivery Contract (IDC), valued at $8,748.97, for the supply of the prescription drug Ocaliva 5 mg tablets. The IDC, which has a total potential value of $499,999,999 and is valid through November 2026, enables the DLA to issue firm...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $17,497.94 firm-fixed-price delivery order is for the supply of Ocaliva 5 mg tablets, with a performance period extending through April 3, 2024. DMS Pharmaceutical Group holds an indefinite-delivery, indefinite-quantity (IDIQ) contract with the DLA, valued at up to $4,999,999 through 2025, to provide a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $69,991.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $35,004.76, is for the delivery of Ocaliva 10 mg tablets on a firm-fixed-price basis, with a period of performance through May 13, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB24FTKGC
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $35,004.76 firm-fixed-price delivery order is for the supply of Ocaliva 10 mg tablets, with a period of performance through October 21, 2024.

This award is associated with a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue firm-fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. This contract vehicle does not have a set-aside designation. Through this IDC and other prime vendor contracts, DMS Pharmaceutical Group serves as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and specialized medications to support the diverse medical requirements of the Department of Defense and its personnel.

Generated 12/27/24, 9:10 AM